BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37199817)

  • 1. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
    Yartsev VD; Atkova EL; Ekaterinchev MA
    Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level.
    Yartsev VD; Sheremeta MS; Trukhin AA; Atkova EL; Degtyarev MV; Yasyuchenya VS; Yudakov DV
    Indian J Ophthalmol; 2023 May; 71(5):1828-1832. PubMed ID: 37203037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic viscosity of the wall of the lacrimal sac in disorders of the patency of the lacrimal ducts.
    Yartsev VD; Novikov IA; Atkova EL; Ekaterinchev MA
    Int Ophthalmol; 2024 Apr; 44(1):171. PubMed ID: 38587686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Acquired Nasolacrimal Duct Obstruction as a Specific Complication of Treatment With Radioactive Iodine (Morphological Study).
    Fedorov AA; Atkova EL; Yartsev VD
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):250-253. PubMed ID: 31743278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhinological Status of Patients with Nasolacrimal Duct Obstruction.
    Yartsev VD; Atkova EL; Rozmanov EO; Yartseva ND
    Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e434-e439. PubMed ID: 35846831
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphological Characteristics of the Lacrimal Apparatus in its Obstruction of Various Genesis.
    Demyashkin GA; Yartsev VD; Atkova EL; Ekaterinchev MA; Shchekin VI
    Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):951-956. PubMed ID: 37206743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biometric characteristics of the lacrimal passages in healthy individuals and in patients with nasolacrimal duct obstruction].
    Atkova EL; Yartsev VD; Ekaterinchev MA; Shkolyarenko NY
    Vestn Oftalmol; 2023; 139(5):20-26. PubMed ID: 37942593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
    Sweeney AR; Davis GE; Chang SH; Amadi AJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):20-25. PubMed ID: 27997463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric Evaluation of Bony Nasolacrimal Canal in a Caucasian Population with Primary Acquired Nasolacrimal Duct Obstruction: A Multidetector Computed Tomography Study.
    Bulbul E; Yazici A; Yanik B; Yazici H; Demirpolat G
    Korean J Radiol; 2016; 17(2):271-6. PubMed ID: 26957913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
    Fonseca FL; Lunardelli P; Matayoshi S
    Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dacryocystorhinostomy with a counteropening in the treatment of secondary nasolacrimal duct obstruction after radioiodine therapy].
    Yartsev VD; Atkova EL; Lipatov DV
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):60-67. PubMed ID: 38739132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer.
    Sakahara H; Yamashita S; Suzuki K; Imai M; Kosugi T
    Ann Nucl Med; 2007 Nov; 21(9):525-7. PubMed ID: 18030585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of 131Iodine in the nasolacrimal sac/duct after radioiodine therapy for papillary thyroid cancer.
    Usmani S; Jain A; Al-Riyami K; Abubakar S
    J Pak Med Assoc; 2023 Mar; 73(3):713-714. PubMed ID: 36932793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the dacryoscintigraphy in patients with nasolacrimal duct obstruction prior to endoscopic dacryocystorhinostomy.
    Kim DJ; Baek S; Chang M
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1535-1540. PubMed ID: 31037489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early trends of secondary acquired nasolacrimal duct obstruction in COVID-19 associated sino-orbital mucormycosis: SALDO update study (SUP) - Paper IV.
    Bothra N; Priya Y; Rincy D; Ali MJ
    Am J Ophthalmol Case Rep; 2024 Jun; 34():102024. PubMed ID: 38426069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomographic dacryocystography in children undergoing balloon dacryoplasty.
    Limongi RM; Magacho L; Matayoshi S; Carneiro HM; Avila M
    J AAPOS; 2012 Oct; 16(5):464-7. PubMed ID: 23084386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Demographic Characteristics of Tearing in Patients after Radioiodine Ablation for Differentiated Thyroid Cancer.
    Yartsev VD; Solodkiy VA; Fomin DK; Borisenko TE; Atkova EL
    Curr Eye Res; 2021 Sep; 46(9):1320-1324. PubMed ID: 33455422
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of CT-DCG in hardware - associated secondary acquired lacrimal duct obstruction: SALDO update study - (SUP) - Paper III.
    Agarwal A; Naik M; Ali MJ; Bothra N
    Am J Ophthalmol Case Rep; 2024 Jun; 34():102026. PubMed ID: 38559363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
    Ali MJ
    Prog Retin Eye Res; 2023 Sep; 96():101193. PubMed ID: 37394093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-dose helical CT-dacryocystography in nasolacrimal duct obstruction-a prospective study].
    Reichel O; Gora F; Dittrich M; Kugler V
    HNO; 2019 Aug; 67(8):600-605. PubMed ID: 31053940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.